 OncLive | Collaboration Across Disciplines Driving Progress in Breast Cancer: A ... OncLive As mTOR inhibitors have become available as an established treatment for renal cell cancer because of the mTOR-driven hypoxia pathways involved in this malignancy, they have also been tested in patients who are on hormonal therapy to prevent the ... |
